Best Oncological Check-up for Man check up doctors: TOP 80 doctors

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Licensed Radiation Oncologist with 8 years of medical training, including undergraduate studies at Marmara University Faculty of Medicine (2004-2011) and Radiation Oncology specialization training at Marmara University Faculty of Medicine (2012-2016). Previous education from Sixteen Numbered Shirvan School (Azerbaijan) High School (1998-2004).

Dr. Asawadech Sanbua

Medical Radiation​ Oncologist

• Passed palliative care training at the Karunrak Center. Khon Kaen University
  
   
• Certificate of oncotherm
  
   
• Expert in treating cancer with oncothermia machines (or hyperthermia machine) 5 years experience.
  
   
• 14 years of experience working in radiotherapy. Able to plan treatment (Planning 2D, 3D, IMRT, VMAT)
  
   
• Can provide chemical treatment, Chemotherapy, targeted drugs therapy) Immunotherapy (Immunotherapy) 

Dr. Özer Akgül is an experienced Turkish Radiation Oncologist, with an MD from Uludag University Medicine School (Bursa) and residency from Ege University Hospital. He has proficiency in overseeing oncology trends, achieving set goals, understanding marketplace needs, and developing strategies. His areas of interest include breast cancer, lung cancer, prostate cancer, rectal cancer, head and neck cancers, cervical cancer, gastric cancer, and brain tumors. He has attended courses and conducted research in Nanobiotechnology, Genetics, Medical Oncology, Gynecologic Cancers, Bioinformatics, Bionanotechnological Methods, Clinical Radiobiology, Medical Radio Physics, Evidence-Based Radiation Oncology, Image-Guided Radiotherapy and Chemotherapy, Varian Advanced Techniques Clinical School, Stereotactic Radiotherapy, and Varian Advanced Imaging (IGRT). He is a member of TROD, Turkish Medical Association, MOKAD, and ESTRO.

1.Bachelor’s degree
- Doctor of medicine, Rangsit university.

2.Master’s degree

>Medical and health science degree
- Professional master’s degree in clinical nutrition in medicine.
- Professional master’s degree in integrative medicine.

>Management degree
- Professional master’s degree in hospital and health services management.

3.Doctorate degree
- Doctorate in psychology (candidate).

4.Diploma
- American Bord of nutritional wellness.
- American naturopathic certification board.

- Certified integrative oncology physician, American institute of integrative oncology.

- Certified wellness physician.

- Certified CBT-I physician.

- Advanced nutritional wellness, IFNW.

-Biochemical and clinical analysis diploma.

- Functional gastroenterology and pediatric food allergies diploma.

- IV nutrition diploma, IFNW.

-Medicinal herbology diploma, IFNW.

• Education:
•  
• 1992- 1998: Middle School - Lyceum of Neapolis, Lassithi, Crete, Greece
• 1999- 2004: Department of Physiotherapy, “Alexander” University of Thessaloniki, Greece
• 2004 - 2010: School of Medicine, University of Crete, Greece
• 2007: Laboratory of Molecular Genetics, Boston University, USA.
• 2010: Department of Mental Health, “Ospedale Maggiore”, Bologna, Italy
• 2017 – 2019: Master of Public Health, EUC, Cyprus
• 2019 – 2023: Doctor of Philosophy (PhD), School of Medicine, University of Crete, Greece

Professional Experience:

• 2010: Medical license
• 2011 - 2012: Rural doctor, Chandras, Crete, Greece
• 2012 - 2017: Resident in Internal Medicine, Department of Internal Medicine, University Hospital of Heraklion, Greece
• 2016: Fellowship at the 1st Department of Internal Medicine, “Konstantopouleio” General Hospital of Nea Ionia, Greece
• 2016: Fellowship at the Infectious Diseases Unit, “Attikon” General Hospital, Greece
• 2017: Specialty degree in Internal Medicine
• 2017. Fellowship at the Infectious Diseases Unit, University Hospital of Heraklion, Greece
• 2017 - 2018. Attending physician, Department of Internal Medicine, University Hospital of Heraklion, Greece
• 2018 - 2020: Specialization in Infectious Diseases, University Hospital of Heraklion and “Attiko” University Hospital of Athens, Greece
• 2020 - 2021: Research Associate, Infectious Diseases Unit, University Hospital of Heraklion, Greece
• 2021: Specialist degree in Infectious Diseases

Memberships:

• Hellenic Society of Infectious Diseases
• Cypriot Society of Clinical Microbiology and Infectious Diseases
• European Society of Clinical Microbiology and Infectious Diseases
• Faculty member of the European Committee on Infection Control (EUCIC)
• Faculty member of the ESCMID Study Group for Antimicrobial Stewardship (ESGAP)
• Board member of the Greek Medical Society for Infectious Diseases in Obstetrics and Gynaecology
• Country Manager of Cyprus of the International Society for Infectious Diseases in Obstetrics and Gynaecology (ISIDOG)

Awards:

• Pancretan Association of the U.S.A. scholarship, 2007: training in Molecular Genetics, Boston University, USA.
• Hellenic AIDS Study scholarship for specialization in Infectious Diseases, 2018 - 2019, Greece
• 2018 – 2024: Representative of Greece as Infectious Disease Specialist in the Trainee Association of ESCMID (TAA) of the European Society for Clinical Microbiology and Infectious Diseases

Academic Experience:

• 2016-2019: Internal Medicine A, 3rd year of undergraduate studies at School of Medicine of Crete, Greece
• 2017-2021: Internal Medicine B, 4th year of undergraduate studies at School of Medicine of Crete, Greece
• 2018-2022: MSc Programme "Public Health & Healthcare Facilities Administration", School of Medicine of Crete, Greece
• 2021: MSc Programme “Emergency and Intensive Care”, School of Medicine, University of Crete, Greece
• 2022-2024: MSc Programme “Public Health”, School of Medicine, University of Patras, Greece
• 2022-2024: MSc Programme “Prevention and Control of clinically severe infections in the Healthcare setting”, School of Medicine, University of Thessaly, Greece

Research Activities:

• 2007: Use of adenoviruses as gene therapy vectors, laboratory researcher, Boston, USA.
• 2018: "Overcome" clinical trial, study co-coordinator, Heraklion, Greece.
• 2019: "REDS" clinical trial, study coordinator, Heraklion, Greece.
• 2019: "Entasis" clinical trial, study coordinator, Heraklion, Greece
• 2019 - 2020: "Rationalizing the use of antibiotics in patients hospitalized at a University Hospital”, principal investigator, University Hospital of Heraklion, Heraklion, Greece

Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.

Education

İnönü Üniversitesi Tıp Fakültesi (ingilizce) 1995- 2002

Work Experience

Başbakanlık S.H.Ç.E.K. Genel Müdürlüğü Kurum Hekimliği (2003)

Erciyes Üniversitesi Tıp Fakültesi Genel Cerrahi Uzmanlığı 2011

Yüzüncü Yıl Üniversitesi Temel ve İleri Düzey Endoskopik Girişimler Eğitimi 2011

İstanbul Hastanesi /Van 2011

Özel Malatya Hastanesi / Malatya2012

Bilgi Tıp Merkezi Keçiören /Ankara 2013

Özel Koru Sincan Hastanesi Sincan/Ankara 2013

Baş Tibb Mərkəzi /Baku Clinic Azerbaycan/Bakü 2013

Yüksek İhtisas Üniversitesi Özel Koru Ankara Hastanesi 2019

Özel Ankara Koru Hastanesi /Ankara 2019

Medical Interests

laparoscopic obesity
Laparoscopic abdominal and inguinal hernia repairs (with the latest techniques)

Postpartum laparascopic diastasis recti (the formation of a protrusion in the upper middle abdomen due to the separation of the muscles in the abdominal tissue) and abdominal hernias above the navel and and gobekustunde both diastasis recti repair and abdominal hernia repair from the skin with laparascopic scola method for the first time in Turkey laparascopic stomach hernia and antireflu surgery).  

Laparoscopic gallbladder surgeries, including cleaning the bile duct with trans-cystic choledochal irrigation in patients with bile sludge and stones less than 5mm in the bile duct, performed in the same session

Laparoscopic gallbladder surgeries in pregnant women during the 2nd and 3rd trimesters, i.e., after 12 weeks of pregnancy

Laparoscopic Appendectomy in Pregnancy

Anal disorders, anal fissures, all types of internal and external hemorrhoid surgeries, anal fissure, and anal fistula surgeries

Thyroid surgeries and cancers, parathyroid surgeries and cancers

Breast diseases and breast cancer surgery

Oncological surgery; liver and gallbladder and bile duct surgeries, stomach cancer surgery, colon cancer surgery, and liver resections for metastatic liver tumors

Dr. Alaa Zedan is a Syrian Internal Medicine Specialist who is board-certified. He got a Master’s degree in Internal Medicine from Aleppo University’s Faculty of Medicine. His expertise in hospitals and clinics in Syria and the United Arab Emirates spans nearly 15 years. His areas of expertise include,

• Controlling diabetes and treatment of both types of diabetes
• Treatment of acute and chronic complications
• Primary and secondary hypertension
• High blood lipids and cholesterol
• Arthritis
• Asthma, bronchitis, acute and chronic chest diseases
• Kidney diseases and follow-up cases of kidney failure and urinary infections
• Gastrointestinal and liver diseases
• Treatment and prevention of deep venous thrombosis
• Follow-up and treatment of heart disease
• Diagnosis and treatment of anemia
• Treatment of headaches of all kinds
• Treatment of infectious diseases

Prof. Dr. Mustafa ÖZATEŞ

Dr Ozates was born in 1966 in Birecik district of Sanliurfa in Turkey. He completed his primary and secondary education in my hometown, Birecik. He got into Istanbul University Istanbul Faculty of Medicine in 1983. After 6 years of successful education, he started Radiology education at Dicle University Faculty of Medicine by passing the Medical Specialization Examination (TUS) in the same year I graduated in 1989.

Between 1993 and 1995, he worked as a Radiology Specialist in various hospitals in Gaziantep. He passed the Assistant Professorship exam and started to work as a faculty member at Dicle University in 1995.

Post-Specialization Trainings:

2003, Gazi University Faculty of Medicine, MRI Department, Ankara

2003, Marmara University Faculty of Medicine, MRI Department, Istanbul

2001-2004, ESNR European Course of Neuroradiology (3 Semesters)

1997, Johns Hopkins University, Neuroradiology, Baltimore, USA

1997, Cornell University, Neuroradiology, New York, USA

1996, Istanbul University Faculty of Medicine, MRI Department, Istanbul

1994, Dokuz Eylül University Faculty of Medicine, MRI Department, İzmir

1993, Uludağ University Faculty of Medicine, MRI Department, Bursa

1993, UCLA Medical Center (as visitor), Los Angles, USA

1992-1993, Maçka EMAR, Dr. Murat Dinçer, Istanbul

His Academic Studies:

International Publications: 23

International Papers: 27

National Publications: 45

National Papers: 48

Conferences: 11

Citations: 210 Scientific Publications (Average Citations per Item: 10.50, h-index: 9), USA edition 1 Book, Various Conferences

Scientific Organizations he is a member of:

European Society of Radiology (ESR)

Turkish Radiology Association (TRD)

Magnetic Resonance Association

Istanbul Medical Chamber (ITO)

Turkish Neuroradiology Association

In 2003, he was awarded the title of Associate Professor with the examination held at Marmara University Faculty of Medicine. In 2005-2013, Dr. Lütfi Kırdar Kartal Training and Research Hospital Radiology Clinic Chief, Training and Administrative Officer.

In 2013, he started to work as a professor at Nişantaşı University. On March 15, 2013, he was appointed as the Inter-University Board Representative for 1 year. He is a Member of the Board of Trustees of Ayvansaray University. He is a sub – specialist in “Pediatric Radiology”

His articles have been published in many magazines in Turkey and abroad. He presented written and oral presentations and gave conferences at congresses in various cities and countries.

As the Radiology Clinic Chief of Bağcılar Training and Research Hospital, he is the first professor who performed Coronary CT Angiography in a state hospital in Istanbul.

He is one of Turkey’s first Children’s Radiology Specialist Minor. He did his military service between March and April 2000 at the 200-bed Malatya Military Hospital.

After graduating with a Medical Degree from Thammasat University, Dr. Chayut worked as an Intern in a Public Hospital for a year’s residency.

For the next 6 years, he found his calling in Aesthetic Medicine Dr. Diacakis has performed enhancement procedures since 2001, and in fact, has been credited as one of the pioneers.

Dr. Chayut and Dr. Diacakis met in 2014 at an Aesthetic Congress in Paris France. He has experience in many procedures such as rhinoplasty, anaplasty, mentoplasty, blepharoplasty, lip reduction, buccal fat removal, and enhancement.

Dr. X is a Medical Oncologist with over 30 years of experience. He has a Medical Education from Istanbul University, specialization in Internal Medicine, and a Medical Oncology Specialization from Istanbul University's Oncology Institute. He is a member of the Medical Oncology Association, Lung Cancers Association, ESMO, ASCO and Istanbul Medical Chamber.